Meeting
2024 ASCO Annual Meeting
Variant of uncertain significance (VUS) genetic testing results and mastectomy choice in lumpectomy-eligible patients.
Authors
Osvaldo Nunez Jr. Jr.
University of Miami Miller School of Medicine, Miami, FL
Osvaldo Nunez Jr. Jr., Vasanth Govind , Tizeta M. Wolde , Rainya Heath , Talia R. Donenberg , Rachel Silva-Smith , Marie B. Jeanjean , Jessica Firdman Moore , Jessica S. Crystal , Susan Kesmodel , Kristin E. Rojas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10601)
DOI
10.1200/JCO.2024.42.16_suppl.10601
Abstract #
10601
Poster Bd #
128
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of germline mutations on surgical decision-making in women with DCIS.
First Author: Rachel E Ellsworth
Poster
2022 ASCO Annual Meeting
Improving access to cancer genetic testing for underserved women in southeast Texas.
First Author: Darya Aleksandrovna Kizub
Poster
2021 ASCO Quality Care Symposium
Fertility preservation in young breast cancer patients: A population-based study.
First Author: Diana Nguyen
Poster
2021 ASCO Annual Meeting
Management impact of preoperative germline genetic testing in patients with breast cancer at the Lifespan Cancer Institute.
First Author: Kaitlyn P. Lew